pSIH1-puro-control shRNA Citations (16)

Originally described in: Sorafenib inhibits STAT3 activation to enhance TRAIL-mediated apoptosis in human pancreatic cancer cells.
Huang S, Sinicrope FA Mol Cancer Ther. 2010 Mar . 9(3):742-50. PubMed Journal

---

Articles Citing pSIH1-puro-control shRNA

Articles
SASP mediates chemoresistance and tumor-initiating-activity of mesothelioma cells. Canino C, Mori F, Cambria A, Diamantini A, Germoni S, Alessandrini G, Borsellino G, Galati R, Battistini L, Blandino R, Facciolo F, Citro G, Strano S, Muti P, Blandino G, Cioce M. Oncogene. 2012 Jun 28;31(26):3148-63. doi: 10.1038/onc.2011.485. Epub 2011 Oct 24. PubMed
Epidermal growth factor receptor signaling impairs the antiviral activity of interferon-alpha. Lupberger J, Duong FH, Fofana I, Zona L, Xiao F, Thumann C, Durand SC, Pessaux P, Zeisel MB, Heim MH, Baumert TF. Hepatology. 2013 Oct;58(4):1225-35. doi: 10.1002/hep.26404. Epub 2013 Sep 5. PubMed
Protein phosphatase 2A impairs IFNalpha-induced antiviral activity against the hepatitis C virus through the inhibition of STAT1 tyrosine phosphorylation. Shanker V, Trincucci G, Heim HM, Duong HT. J Viral Hepat. 2013 Sep;20(9):612-21. doi: 10.1111/jvh.12083. Epub 2013 Mar 12. PubMed
G-CSF Promotes Neuroblastoma Tumorigenicity and Metastasis via STAT3-Dependent Cancer Stem Cell Activation. Agarwal S, Lakoma A, Chen Z, Hicks J, Metelitsa LS, Kim ES, Shohet JM. Cancer Res. 2015 Jun 15;75(12):2566-79. doi: 10.1158/0008-5472.CAN-14-2946. Epub 2015 Apr 23. PubMed
Signal Transducer and Activator of Transcription 3, Mediated Remodeling of the Tumor Microenvironment Results in Enhanced Tumor Drug Delivery in a Mouse Model of Pancreatic Cancer. Nagathihalli NS, Castellanos JA, Shi C, Beesetty Y, Reyzer ML, Caprioli R, Chen X, Walsh AJ, Skala MC, Moses HL, Merchant NB. Gastroenterology. 2015 Dec;149(7):1932-1943.e9. doi: 10.1053/j.gastro.2015.07.058. Epub 2015 Aug 7. PubMed
ARID1A ablation leads to multiple drug resistance in ovarian cancer via transcriptional activation of MRP2. Luo Q, Wu X, Zhang Y, Shu T, Ding F, Chen H, Zhao P, Chang W, Zhu X, Liu Z. Cancer Lett. 2018 Jul 28;427:9-17. doi: 10.1016/j.canlet.2018.04.013. Epub 2018 Apr 13. PubMed
A Synthetic Disaccharide Derivative of Diphyllin, TAARD, Activates Human Natural Killer Cells to Secrete Interferon-Gamma via Toll-Like Receptor-Mediated NF-kappaB and STAT3 Signaling Pathways. Yi L, Chen L, Guo X, Lu T, Wang H, Ji X, Zhang J, Ren Y, Pan P, Kinghorn AD, Huang X, Wang LS, Fan Z, Caligiuri MA, Yu J. Front Immunol. 2018 Jul 18;9:1509. doi: 10.3389/fimmu.2018.01509. eCollection 2018. PubMed
SERPINE2 promotes esophageal squamous cell carcinoma metastasis by activating BMP4. Zhang J, Luo A, Huang F, Gong T, Liu Z. Cancer Lett. 2020 Jan 28;469:390-398. doi: 10.1016/j.canlet.2019.11.011. Epub 2019 Nov 12. PubMed
A promising approach to develop nanostructured lipid carriers from solid lipid nanoparticles: preparation, characterization, cytotoxicity and nucleic acid binding ability. Oner E, Kotmakci M, Kantarci AG. Pharm Dev Technol. 2020 May 14:1-13. doi: 10.1080/10837450.2020.1759630. PubMed
DRP1 Promotes BRAF(V600E)-Driven Tumor Progression and Metabolic Reprogramming in Colorectal Cancer. Padder RA, Bhat ZI, Ahmad Z, Singh N, Husain M. Front Oncol. 2021 Mar 2;10:592130. doi: 10.3389/fonc.2020.592130. eCollection 2020. PubMed
Activated STAT3 Is a Novel Regulator of the XRCC1 Promoter and Selectively Increases XRCC1 Protein Levels in Triple Negative Breast Cancer. Wright G, Sonavane M, Gassman NR. Int J Mol Sci. 2021 May 22;22(11). pii: ijms22115475. doi: 10.3390/ijms22115475. PubMed
STAT3 inhibition suppresses adaptive survival of ALK-rearranged lung cancer cells through transcriptional modulation of apoptosis. Yanagimura N, Takeuchi S, Fukuda K, Arai S, Tanimoto A, Nishiyama A, Ogo N, Takahashi H, Asai A, Watanabe S, Kikuchi T, Yano S. NPJ Precis Oncol. 2022 Feb 28;6(1):11. doi: 10.1038/s41698-022-00254-y. PubMed
Identification of a Metastasis-Related Protein IFI16 in Esophageal Cancer using a Proteomic Approach. Wang Z, Sheng B, Wei Z, Li Y, Liu Z. J Cancer. 2022 Mar 6;13(5):1630-1639. doi: 10.7150/jca.59286. eCollection 2022. PubMed
MAFB promotes the malignant phenotypes by IGFBP6 in esophageal squamous cell carcinomas. Zhang S, Gong T, Nan Y, Feng R, Liu Z, Chen H. Exp Cell Res. 2022 Jul 1;416(1):113158. doi: 10.1016/j.yexcr.2022.113158. Epub 2022 Apr 14. PubMed
The Deubiquitinase USP39 Promotes Esophageal Squamous Cell Carcinoma Malignancy as a Splicing Factor. Zhu X, Ma J, Lu M, Liu Z, Sun Y, Chen H. Genes (Basel). 2022 May 3;13(5). pii: genes13050819. doi: 10.3390/genes13050819. PubMed
DLGAP1-AS2-Mediated Phosphatidic Acid Synthesis Activates YAP Signaling and Confers Chemoresistance in Squamous Cell Carcinoma. Nan Y, Luo Q, Wu X, Liu S, Zhao P, Chang W, Zhou A, Liu Z. Cancer Res. 2022 Aug 16;82(16):2887-2903. doi: 10.1158/0008-5472.CAN-22-0717. PubMed

If you have published an article using this material, please email us at to have your article added to this page.